Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and approve unaudited financial standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sampre Nutritions has called a Board Meeting on 5 November 2025 to approve unaudited standalone and consolidated financial results for the second quarter and half year ended 30 September 2025. The Board will also consider issuing sweat equity shares to eligible employees and directors. Additionally, the Board plans to convert an unsecured loan given by the promoter into equity shares of the Company, which will strengthen the equity base.
The conversion of the promoter's unsecured loan into equity is positive for shareholders as it reduces debt and lowers financial risk, though it may dilute existing shareholding. Investors should watch the upcoming Q2 results for actual revenue and profit performance.